Capecitabine-Related Eruption Mimicking Dermatomyositis in 2 Patients With Metastatic Breast Cancer

JAMA Dermatol. 2020 Jan 1;156(1):103-104. doi: 10.1001/jamadermatol.2019.3162.

Authors

Gabriela A Cobos¹, Caroline A Nelson¹, Abeer Alsarheed¹, Avery LaChance¹, Alvaro C Laga², Nicole LeBoeuf^{2

3}, Ruth Ann Vleugels¹

Affiliations

¹ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

PMID: 31693064
DOI: 10.1001/jamadermatol.2019.3162

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antimetabolites, Antineoplastic / adverse effects*
Breast Neoplasms / drug therapy*
Capecitabine / adverse effects*
Dermatomyositis / diagnosis*
Diagnosis, Differential
Female
Hand-Foot Syndrome / diagnosis*
Hand-Foot Syndrome / etiology
Humans
Middle Aged

Substances

Antimetabolites, Antineoplastic
Capecitabine